Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026)

Elanco Animal Health (ELAN) reported Non-Current Debt of $3.7 billion for Q1 2026, down 14.13% on a YoY basis from $4.4 billion in Q1 2025, and down 0.69% sequentially from $3.8 billion in Q4 2025.

Elanco Animal Health (ELAN) Non-Current Debt (2018 - 2026) Analysis & Trends

Elanco Animal Health (ELAN) has 9 years of Non-Current Debt data on file, last reported at $3.7 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt fell 14.13% year-over-year to $3.7 billion; the trailing twelve-month figure through Mar 2026 stood at $3.7 billion (down 14.13% YoY), and the FY2025 full-year result was $3.8 billion, down 12.04% from the prior year.
  • Non-Current Debt slipped to $3.7 billion in Q1 2026, from $3.8 billion in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $6.1 billion in Q1 2022 to a low of $3.7 billion in Q1 2026.
  • A 5-year average of $5.0 billion and a median of $5.4 billion in 2022 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt advanced 5.98% in 2023 and slipped 28.72% in 2024, its largest moves.
  • Tracing ELAN's Non-Current Debt over 5 years: stood at $5.4 billion in 2022, then gained by 5.98% to $5.8 billion in 2023, then declined by 25.93% to $4.3 billion in 2024, then dropped by 12.04% to $3.8 billion in 2025, then retreated by 0.69% to $3.7 billion in 2026.
  • Business Quant data shows ELAN's Non-Current Debt at $3.7 billion in Q1 2026, $3.8 billion in Q4 2025, and $4.0 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 197.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.74 Bn
Dec 31, 2025 3.76 Bn
Sep 30, 2025 3.96 Bn
Jun 30, 2025 4.15 Bn
Mar 31, 2025 4.35 Bn
Dec 31, 2024 4.28 Bn
Sep 30, 2024 4.36 Bn
Jun 30, 2024 4.32 Bn
Mar 31, 2024 5.73 Bn
Dec 31, 2023 5.77 Bn
Sep 30, 2023 5.87 Bn
Jun 30, 2023 6.06 Bn
Mar 31, 2023 5.64 Bn
Dec 31, 2022 5.45 Bn
Sep 30, 2022 5.90 Bn
Jun 30, 2022 6.01 Bn
Mar 31, 2022 6.13 Bn
Dec 31, 2021 6.32 Bn
Sep 30, 2021 6.33 Bn
Jun 30, 2021 6.10 Bn